These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 637526)

  • 21. [Morphofunctional changes in the mycelium of active and inactive variants of Actinomyces parvullus during growth and biosynthesis of actinomycin D].
    Zaslavkaia PL; Zhukov VG
    Mikrobiologiia; 1976; 45(6):1035-9. PubMed ID: 1012045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-factor, an essential regulatory substance inducing the production of rifamycin in a Nocardia sp.
    Kawaguchi T; Asahi T; Satoh T; Uozumi T; Beppu T
    J Antibiot (Tokyo); 1984 Dec; 37(12):1587-95. PubMed ID: 6526727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosynthesis of rifamycin SV by Amycolatopsis mediterranei MTCC17 in solid cultures.
    Krishna PS; Venkateswarlu G; Pandey A; Rao LV
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):311-5. PubMed ID: 12546705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of the structure of colonies of active and inactive Actinomyces parvullus variants using luminescence and scanning microscopy].
    Zaslavskaia PL; Zhukov VG; Kuznetsov VD
    Antibiotiki; 1975 Apr; 20(4):329-32. PubMed ID: 1211901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overproduction of rifamycin B by Amycolatopsis mediterranei and its relationship with the toxic effect of barbital on growth.
    Mejía A; Barrios-González J; Viniegra-González G
    J Antibiot (Tokyo); 1998 Jan; 51(1):58-63. PubMed ID: 9531988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation of rifamycin S into rifamycins B and L. A revision of the current biosynthetic hypothesis.
    Ghisalba O; Roos R; Schupp T; Nüesch J
    J Antibiot (Tokyo); 1982 Jan; 35(1):74-80. PubMed ID: 7200089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of B-factor and its analogues on rifamycin biosynthesis in Nocardia sp.
    Kawaguchi T; Azuma M; Horinouchi S; Beppu T
    J Antibiot (Tokyo); 1988 Mar; 41(3):360-5. PubMed ID: 3366694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of rifemycins production by Amycolatopsis mediterranei in batch and fed-batch cultures.
    El-Enshasy HA; Beshay UI; El-Diwany AI; Omar HM; El-Kholy AG; El-Najar R
    Acta Microbiol Pol; 2003; 52(3):301-13. PubMed ID: 14743983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic recombination in Nocardia mediterranei.
    Schupp T; Hutter R; Hopwood DA
    J Bacteriol; 1975 Jan; 121(1):128-36. PubMed ID: 1116983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic recombination in Nocardia mediterranei].
    Schupp T; Huetter R
    Pathol Microbiol (Basel); 1974; 40(3):149-50. PubMed ID: 4843095
    [No Abstract]   [Full Text] [Related]  

  • 31. Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening.
    Jin ZH; Lin JP; Xu ZN; Cen PL
    J Gen Appl Microbiol; 2002 Dec; 48(6):329-34. PubMed ID: 12682871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential mass spectrometry-based proteome analyses unveil major regulatory hubs in rifamycin B production in Amycolatopsis mediterranei.
    Singhvi N; Singh P; Prakash O; Gupta V; Lal S; Bechthold A; Singh Y; Singh RK; Lal R
    J Proteomics; 2021 May; 239():104168. PubMed ID: 33662614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Hydroxyrifamycin S and further novel ansamycins from a recombinant strain R-21 of Nocardia mediterranei.
    Traxler P; Schupp T; Fuhrer H; Richter WJ
    J Antibiot (Tokyo); 1981 Aug; 34(8):971-9. PubMed ID: 7319930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 16,17-dihdrorifamycin S and 16,17-dihydro-17-hydroxyrifamycin S. Two novel rifamycins from a recombinant strain C 5/42 of Nocardia mediterranei.
    Traxler P; Schupp T; Wehrli W
    J Antibiot (Tokyo); 1982 May; 35(5):594-601. PubMed ID: 7107523
    [No Abstract]   [Full Text] [Related]  

  • 35. [Phosphate control to rifamycin SV biosynthesis].
    Ni LY; Chiao JS
    Wei Sheng Wu Xue Bao; 1988 Dec; 28(4):340-5. PubMed ID: 3247718
    [No Abstract]   [Full Text] [Related]  

  • 36. Thiazorifamycins. III. Biosynthesis of rifamycins P, Q and verde, novel metabolites from a mutant of Nocardia mediterranea.
    Cricchio R; Antonini P; Sartori G
    J Antibiot (Tokyo); 1980 Aug; 33(8):842-6. PubMed ID: 7429988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Morphofunctional study of the development of Actinomyces aureofaciens under conditions of regulated and unregulated fermentation].
    Zaslavskaia PL; Makarevich VG; Slugina MD
    Mikrobiologiia; 1977; 46(2):283-7. PubMed ID: 407427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribonucleases catalyze the synthesis of B-factor (3'-butylphosphoryl AMP), an inducer of rifamycin production in a Nocardia sp.
    Azuma M; Nishi K; Horinouchi S; Beppu T
    J Antibiot (Tokyo); 1990 Mar; 43(3):321-3. PubMed ID: 2157696
    [No Abstract]   [Full Text] [Related]  

  • 39. [Electron microscopic study of the structure of colonies of culture of Actinomyces parvullus producing actinomycin D].
    Zaslavskaia PL; Zhukov VG; Kuznetsov VD; Berezina EK
    Antibiotiki; 1976 May; 21(5):399-403. PubMed ID: 1023810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of rifamycin B fermentation in shake flasks via a machine-learning-based approach.
    Bapat PM; Wangikar PP
    Biotechnol Bioeng; 2004 Apr; 86(2):201-8. PubMed ID: 15052640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.